Stanford University
Showing 10,801-10,850 of 34,464 Results
-
Halldora Gudmundsdottir
Ph.D. Student in Energy Resources Engineering, admitted Autumn 2014
Current Research and Scholarly InterestsMy PhD research focuses on developing predictive models for geothermal systems. I am interested in direct predictions of the future performance of geothermal reservoirs as well as characterization of the subsurface flow behavior that can aid in operational decision making. Currently, I am incorporating principles from statistics and artificial intelligence into workflows that can be used for production and injection optimization.
-
Murilo Guedes
Fellow in Medicine - Med/Nephrology
BioMurilo Guedes, MD, PhD, is a Fellow in Medicine within the Department of Nephrology and part of the Translational Investigator Program (TIP) within the Department of Medicine at Stanford.
Dr. Guedes’s research is dedicated to improving the lives of patients with chronic kidney disease. His work draws on clinical epidemiology, international patient cohorts, and clinical trials to identify opportunities to improve care across the spectrum of kidney disease. A central focus is understanding how anemia and iron deficiency relate to cardiovascular outcomes, survival, physical function, and quality of life, including the implications of iron deficiency beyond anemia.
His research also examines how dialysis treatments and differences in clinical practice relate to patients’ health and daily experiences, with particular attention to fatigue, physical activity, and recovery after dialysis. His broader work explores gaps in kidney disease detection, risk assessment, and treatment. Across these efforts, he aims to translate clinical evidence into practical strategies that reduce the burden of kidney disease and help patients live longer, healthier lives. -
Lori Guelman, MSN, RN, FNP-BC
Affiliate, Central Mgmt-Misc AR
BioLori Guelman, RN, MSN, FNP – BC recently took on the role of lead advanced practice provider (APP) for the Stanford Urology Oncology and Radiology Oncology clinics. Prior to this, she worked in general urology for over twelve years. Lori has presented at numerous local and international conferences on topics ranging from overactive bladder, dysuria and neuromodulation to pain management and the role of the NP. She was most recently invited to speak at the APP section of the American Urological Association’s 2019 Annual conference on antibiotic resistance. Her research on simple cystitis and antibiotic stewardship was recently published in the Nov/Dec 2019 Urologic Nursing Journal, affiliated with Society of Urologic Nurses and Associates (SUNA). Lori is currently a co-facilitator for the ACES relationship-centered communication workshops as well as faculty for the APP mentorship program. Lori has been very active in the Stanford Advanced Practice Provider (APP) community and has recently stepped down as the former chair and faculty for the Stanford Healthcare controlled substances program as well as the APP quarterly newsletter and APP awards committee. Lori is the past president of the Golden Gate Chapter/San Francisco chapter for the California Association of Nurse Practitioners in which she completed two terms.
-
Brandon Alan Guenthart
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Guenthart is a board-certified, fellowship-trained cardiothoracic surgeon. He is a clinical assistant professor in the Department of Cardiothoracic Surgery.
He specializes in providing leading-edge surgical treatment for people with cancer and end-stage heart and lung disease. He performs the full range of surgical procedures ranging from minimally invasive thoracic surgery to heart and lung transplantation. Dr. Guenthart practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the airway, lung, mediastinum, esophagus, and foregut. He has a particular interest in minimally invasive techniques and has extensive experience in video-assisted thoracoscopic surgical (VATS), laparoscopic, robotic, endoscopic, and bronchoscopic approaches.
Dr. Guenthart earned his medical degree at Temple University School of Medicine. He completed general surgery residency at Cornell and a post-doctoral research fellowship in tissue bioengineering at Columbia University in the Laboratory for Stem Cells and Tissue Engineering. He then completed cardiothoracic surgery fellowship and advanced fellowship training in cardiothoracic transplantation and mechanical circulatory support at Stanford University.
Dr. Guenthart has conducted research supported by grants from the National Institutes of Health, Stanford University School of Medicine, and Columbia University. Dr. Guenthart has a particular interest in end-stage lung disease and his research focuses on lung perfusion and bioengineering strategies to promote lung recovery and regeneration. He has published in peer-reviewed journals such as Nature Medicine, Nature Biomedical Engineering, the Journal of Heart and Lung Transplantation. He has made numerous presentations to his peers at national conferences and given invited talks on patient selection, organ allocation, and other aspects of transplantation.
Dr. Guenthart is a member of the Society of Thoracic Surgeons, Western Thoracic Surgical Association, Biomedical Engineering Society, American College of Surgeons, Association for Academic Surgery, and Alpha Omega Alpha Medical Honor Society. -
Allison Guerin
Senior Director of Education, Engagement & Opportunity, Pediatrics
Current Role at StanfordSenior Director of Education, Engagement & Opportunity, Department of Pediatrics
-
Carlos Ernesto Guestrin
Fortinet Founders Professor and Senior Fellow at the Stanford Institute for Human-Centered AI
On Leave from 2026-10-01 To 2026-12-31BioCarlos Guestrin is a Professor in the Computer Science Department at Stanford University. His previous positions include the Amazon Professor of Machine Learning at the Computer Science & Engineering Department of the University of Washington, the Finmeccanica Associate Professor at Carnegie Mellon University, and the Senior Director of Machine Learning and AI at Apple, after the acquisition of Turi, Inc. (formerly GraphLab and Dato) — Carlos co-founded Turi, which developed a platform for developers and data scientist to build and deploy intelligent applications. He is a technical advisor for OctoML.ai. His team also released a number of popular open-source projects, including XGBoost, LIME, Apache TVM, MXNet, Turi Create, GraphLab/PowerGraph, SFrame, and GraphChi.
Carlos received the IJCAI Computers and Thought Award and the Presidential Early Career Award for Scientists and Engineers (PECASE). He is also a recipient of the ONR Young Investigator Award, NSF Career Award, Alfred P. Sloan Fellowship, and IBM Faculty Fellowship, and was named one of the 2008 ‘Brilliant 10’ by Popular Science Magazine. Carlos’ work received awards at a number of conferences and journals, including ACL, AISTATS, ICML, IPSN, JAIR, JWRPM, KDD, NeurIPS, UAI, and VLDB. He is a former member of the Information Sciences and Technology (ISAT) advisory group for DARPA. -
Junna Gui
Assistant Director QFARM, Ginzton, E.L. Laboratory
Current Role at StanfordQ-Farm Program Manager
-
Leonidas Guibas
Paul Pigott Professor of Engineering and Professor, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsGeometric and topological data analysis and machine learning. Algorithms for the joint analysis of collections of images, 3D models, or trajectories. 3D reconstruction.
-
Gemma Guilera Ferre
Managing Director, Sustainability Accelerator
BioDr. Gemma Guilera is a chemist, an entrepreneur and an enabler of innovation. She currently serves as a Managing Director at the Sustainability Accelerator within the Stanford Doerr School of Sustainability.
Prior to joining the Accelerator, Guilera was Senior Manager at Plug and Play tech Center, an innovation platform and early-stage startup investment firm in Silicon Valley. Specializing in sustainable materials and packaging, she facilitated relationships between corporations seeking innovative solutions and the dynamic startup network at Plug and Play. Earlier to this role, Guilera was co-founder and CEO of Moving Beans, a venture backed-up sustainable startup developing more environmentally friendly, home-compostable materials for consumer goods.
During her time in the UK, Guilera was part of the original team that implemented the human-centered, solution-led Accelerator for Cities at Connected Places Catapult, where she led the startup team. The team provided support to startups in their growth journey through strategic multi-stakeholder engagement and accelerator programs. She also developed and led the open call for one of the largest large-scale IoT demonstrators globally, now the EU standard for innovative open calls.
Prior to her work in innovation, Guilera built the X-Ray Absorption Spectroscopy Beamline at ALBA Synchrotron (Spain), overseeing its construction and operation and conducting research in various areas such as catalysis and nanomaterials. Her career began as an industrial post-doc, followed by her role as a scientist at the ESRF (European Synchrotron Radiation Facility), where she worked in the field of heterogeneous catalysis and collaborated with Toyota to co-develop a three-way catalyst for petrol cars.
Gemma holds a BSc in Chemistry from the University of Barcelona, as well as an MSc in Supramolecular Chemistry and a PhD in Organometallic Chemistry from King’s College London. She was selected as one of the finalists in Women in Tech Global Awards 2021. -
Ilang M. Guiroy, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Ilang M. Guiroy is a board-certified, fellowship-trained physician scientist and psychiatrist at Stanford Health Care and Lucile Packard Children’s Hospital Stanford. She is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Guiroy is director of the Guiroy Lab at Stanford. Her research explores maternal-infant mental health and digital mental health, including the use of social media, digital communities, and AI for mental health. She developed a groundbreaking telehealth platform to deliver psychotherapy via group chat to digital communities.
Dr. Guiroy treats mental health conditions in patients throughout the lifespan, from conception to elder age. She has a special interest in infant, child, and maternal mental health and provides medication management during pregnancy, postpartum, and breastfeeding. Dr. Guiroy provides expert support to patients coping with birth trauma, transitioning to motherhood, and fostering infant attachment and maternal bonding. Dr. Guiroy is skilled in over twelve therapy modalities including maternal-infant dyadic therapy, interpersonal therapy (IPT), and cognitive behavioral therapy (CBT).
Dr. Guiroy has published her research in peer-reviewed journals, including Journal of Technology in Behavioral Science and Telemedicine and e-Health. She has also presented to her peers at national conferences for the American Academy of Child and Adolescent Psychiatry (AACAP) and the Society for Digital Mental Health (SDMH).
Dr. Guiroy is a member of the AACAP, the SDMH, the American Psychiatric Association (APA), and the International Marcé Society for Perinatal Mental Health. -
Isabelle GUIS
Fall 2026 CSP instructor BUS 308, Continuing Studies
BioIsabelle Guis is a marketing AI practitioner-scholar recognized as a 2025 Global Top 100 B2B CMO. She brings over 20 years of executive leadership experience at Salesforce, Dell/EMC, Cisco, and Commvault. A former chief marketing officer and chief strategy officer, she now focuses on teaching, research, and advising organizations on data-driven marketing and responsible AI adoption. She received an MBA from Harvard and an MS in electrical engineering and computer science from CentraleSupélec in Paris.
-
Kip E. Guja, MD PhD
Clinical Assistant Professor, Radiology - Rad/Nuclear Medicine
Current Research and Scholarly InterestsMy current research interests include:
1) PET/MR and PET/CT imaging in children and adults, for oncologic and non-oncologic indications
2) Targeted radionuclide therapy and theragnostics
3) Pre-clinical development and clinical translation of novel radiopharmaceuticals
